| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/22/2009 | EP2049144A2 Glycosylation of peptides via o-linked glycosylation sequences |
| 04/22/2009 | EP2049083A2 Stabilisation by preparing cyclodextrin inclusion complexes |
| 04/22/2009 | EP2049082A2 Reagents, methods and systems to suppress pro-inflammatory cytokines |
| 04/22/2009 | EP2048948A2 Liquid compositions of calcium acetate |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1515704B1 Microcapsules for the delayed, controlled release of perindopril |
| 04/22/2009 | EP1487409B1 Highly aqueous liquid carrier formulations |
| 04/22/2009 | EP1480630B1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 04/22/2009 | EP1368004B1 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 04/22/2009 | EP1317419B1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/22/2009 | EP1267937B1 Polysaccharide-polypeptide conjugate |
| 04/22/2009 | EP1200455B1 Enzyme catalyzed therapeutic activation |
| 04/22/2009 | EP1146890B1 Buccal delivery system for proteinaceous medicaments |
| 04/22/2009 | EP1049459B1 Oral liquid compositions |
| 04/22/2009 | CN101415732A Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 04/22/2009 | CN101415730A Compositions and methods of use for antibodies of c-Met |
| 04/22/2009 | CN101415727A Binder for C-reactive protein |
| 04/22/2009 | CN101415721A Compositions for purifying and crystallizing molecules of interest |
| 04/22/2009 | CN101415464A Solid oral compositions based on s-adenosyl methionine and/or NADH and process for obtaining them |
| 04/22/2009 | CN101415445A Pegylated factor VIII |
| 04/22/2009 | CN101415444A Biodegradable cationic polymers |
| 04/22/2009 | CN101415443A Compositions of stabilized DNA for coating microprojctions |
| 04/22/2009 | CN101415442A Controlled release gels |
| 04/22/2009 | CN101415404A A tablet of paracetamol containing an encapsulated flavorant |
| 04/22/2009 | CN101415402A UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an uv-absorbing component |
| 04/22/2009 | CN101415395A Casein nanoparticle |
| 04/22/2009 | CN101412806A Amphiprotic polymer, and preparation and use thereof |
| 04/22/2009 | CN101412742A Nitric acid ester medicament for inhibiting angiogenesis |
| 04/22/2009 | CN101411879A SiO2/Au nano material with nucleocapsid structure-biological protein medicament complex and preparation method thereof |
| 04/22/2009 | CN101411878A Method for anchoring growth factor on material with biodegradability |
| 04/22/2009 | CN101411877A Method for preparing thermosensitive nano medicament carrier with dual-target magnetism and folacin |
| 04/22/2009 | CN101411876A Neurotoxic oligomers |
| 04/22/2009 | CN101411875A Preparation for preparing pig serum immunoglobulin long-acting dosage form |
| 04/22/2009 | CN101411874A Preparation for preparing dog serum immunoglobulin long-acting dosage form |
| 04/22/2009 | CN101411871A Method for preparing chicken thymosin long-acting dosage form |
| 04/22/2009 | CN101411870A Method for preparing chicken interferon long-acting sustained-release dosage form |
| 04/22/2009 | CN101411869A Method for preparing pig interferon long-acting injection dosage form |
| 04/22/2009 | CN101411868A Method for preparing dog interferon long-acting injection dosage form |
| 04/22/2009 | CN101411867A Method for preparing chicken interleukin-2 long-acting dosage form |
| 04/22/2009 | CN101411864A Thymopentin dry powder formulation and preparation method thereof |
| 04/22/2009 | CN101411851A Chinese medicinal composition for preventing and treating hyperlipemia symptom and atherosclerosis |
| 04/22/2009 | CN101411748A Salvia root total phenolic acid tablet and preparation method thereof |
| 04/22/2009 | CN101411747A Salvia root polyphenol acid orally disintegrating tablets and preparation method thereof |
| 04/22/2009 | CN101411740A Dropping pills for treating cardiovascular disease and preparation method thereof |
| 04/22/2009 | CN101411724A Composition for preventing flocculation and delamination of bee honey and royal jelly oral liquid and processing method |
| 04/22/2009 | CN101411715A Pharmaceutical composition containing acarbose |
| 04/22/2009 | CN101411701A Vitamin C microcapsule formulation and preparation method thereof |
| 04/22/2009 | CN101411691A Method for preparing Cydiodine lozenge and Cydiodine lozenge |
| 04/22/2009 | CN101411686A Clarithromycin sub-microemulsion injection and preparation method thereof |
| 04/22/2009 | CN101411685A Intravenous anesthetics 2,6-diisopropyl phenol microemulsion composition and method of making the same |
| 04/22/2009 | CN100480275C Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing the complexes |
| 04/22/2009 | CN100480274C Hydroxyalkyl starch derivatives |
| 04/22/2009 | CN100480258C Purified LH (Luteinizing hormone) |
| 04/22/2009 | CN100479930C Biological control of nanoparticles |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479861C Intensified additive for chondroitin sulfate capsule formulation and tablet and preparation method thereof |
| 04/22/2009 | CN100479856C Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 04/22/2009 | CN100479822C Clozapine encapsulated solid lipid microparticle and preparation process thereof |
| 04/22/2009 | CN100479821C Cefditoren pivoxil dry suspensoid and preparing process thereof |
| 04/22/2009 | CN100479820C Itraconazole liposome and preparation process thereof |
| 04/22/2009 | CN100479809C Oral disintegration preparation and preparing method thereof |
| 04/22/2009 | CN100479807C Medicine conveying system--preparation method of solid nano medicine |
| 04/22/2009 | CN100479806C Nanostructured liposome vector with highly effective antineoplastic activity |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521440 Targeted oxidative therapeutic formulation |
| 04/21/2009 | US7521436 Modified phosphocalcic compound, injectable composition containing same |
| 04/21/2009 | US7521433 Complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/21/2009 | US7521424 Albumin fusion proteins |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521225 Alumina; phopholipid; arrays, membrane biochips, and protein biochips; affinity purification, catalysis |
| 04/21/2009 | US7521197 Method for producing cytotoxic T-cells |
| 04/21/2009 | US7521069 Methods and compositions for pulmonary delivery of insulin |
| 04/21/2009 | US7521066 Administering non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect and anticancer agent |
| 04/21/2009 | US7521065 Compositions for the treatment and prevention of cancer |
| 04/21/2009 | US7521061 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 04/21/2009 | US7521054 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/21/2009 | CA2434964C Carrier with solid fibrinogen and solid thrombin |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2380068C Pullulan film compositions |
| 04/21/2009 | CA2339147C Stabilized preparations of .beta.-lactam antibiotic |
| 04/21/2009 | CA2338358C Compounds and compositions for delivering active agents |
| 04/21/2009 | CA2320878C Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/21/2009 | CA2299420C Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 04/21/2009 | CA2221341C Submicron liposome suspensions obtained from preliposome lyophilizates |
| 04/19/2009 | CA2641248A1 Patch preparation |
| 04/16/2009 | WO2009048993A2 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators |
| 04/16/2009 | WO2009048959A1 Rapid acting injectable insulin compositions |
| 04/16/2009 | WO2009048958A2 Methods and compositions involving chitosan nanoparticles |
| 04/16/2009 | WO2009048945A1 Rapid mucosal gel or film insulin compositions |
| 04/16/2009 | WO2009048841A1 Antifungal treatment of nails |
| 04/16/2009 | WO2009048532A2 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 04/16/2009 | WO2009048280A2 Long acting hyaluronic acid - peptide conjugate |
| 04/16/2009 | WO2009048166A1 Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy |
| 04/16/2009 | WO2009048122A1 Process for producing highly purified orange roughy oil |
| 04/16/2009 | WO2009048120A1 Water-soluble composition containing astaxanthin |
| 04/16/2009 | WO2009048073A1 Method of coating granules |
| 04/16/2009 | WO2009047928A1 Method of producing functional dna, transformant and remedy for disease |